If your losing sleep over their wording than you should probably move on to calmer pastures.
SNTA is just like all the other biopharma spec stocks out there, could be a home run or a strikeout.
Nice pop today, also I haven't noticed any insider selling either. Good Luck.
I usually don't respond to idiotic comparisons either, but since you been touting ACAD since the mid $2 (your words) I thought you'd want to tell everyone the loads of money you made on stock.
I invested because of their pipeline and considered any pps under $4 a good entry point.
We shall see, I been wrong before.
Also, my time horizon is longer than 6 months. If they don't execute I'll cut my losses (if any) and move on.
You invested in a medical device company not a spec biopharma.
Huge increases aren't likely, especially not at this juncture.
I'm pretty sure encouraging means encouraging.
If you need more help, consult your dictionary.
Why are you constantly comparing a medical device company to two biopharma companies? Are you stupid or just an idiot? May be both?
Suppression of NeuVax by AF resulting in deaths. Your kidding right?
I heard they believe the stock will hit $60 tomorrow before noon, then crash to somewhere in the mid $2 range.
I'd sell early if I were you.
Sounds logically, but you never know, could keep running. A lot of hype right now.
I thought it would sell off more today.
I would doubt a buyout would be priced any higher than the stock is now.
The FDA has shown that the process can slow down, also.
$1.6 is just dumb, but I can see it drifting down to $10 easily.
Don't understand how their EPS would change since they haven't begun selling the drug yet.
Maybe they're planning on winning the Poweball.